Read + Share
Amedeo Smart
Independent Medical Education
Pagano G, Monnet A, Reyes A, Ribba B, et al. Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial. Nat Med 2024 Oct 8. doi: 10.1038/s41591-024-03270.PMID: 39379705
Email
LinkedIn
Privacy Policy